These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 4200296)
21. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases]. Ionescu V Dtsch Med Wochenschr; 1971 May; 96(20):867-70. PubMed ID: 5280862 [No Abstract] [Full Text] [Related]
22. [Conventional and aggressive chemo-radiotherapy of chronic granulocytic leukemia in its different phases. Other therapeutic problems]. GarciĆ”-Conde J; Alberola V; Lluch A; Escrig V Sangre (Barc); 1984; 29(4-B):577-97. PubMed ID: 6393383 [No Abstract] [Full Text] [Related]
31. The effect of splenectomy in chronic granulocytic leukemia. Report of a case. Cutting HO Arch Intern Med; 1967 Sep; 120(3):356-60. PubMed ID: 5231845 [No Abstract] [Full Text] [Related]
32. [Splenectomy and polychemotherapy in chronic myelosis]. Fleischer J Z Gesamte Inn Med; 1979 Jun; 34(12):148-9. PubMed ID: 292262 [TBL] [Abstract][Full Text] [Related]
33. [Therapy of chronic myeloid leukemia]. Mey U Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):268-74. PubMed ID: 6168538 [No Abstract] [Full Text] [Related]
34. [Hydroxyurea in the treatment of chronic myeloid leukemia]. Pensabene A; Cipriani D Haematol Lat; 1969; 12(3):767-70. PubMed ID: 5273184 [No Abstract] [Full Text] [Related]
35. [Preliminary studies on the effectiveness of the association cytosine-arabinoside, thioguanine, hydroxyureas in the treatment of blastic crisis in chronic myeloid leukemia]. Papa G; Amadori S; Monarca B; Alimena G; Esposito A; Mandelli F Haematologica; 1972; 58(9):597-600. PubMed ID: 4206235 [No Abstract] [Full Text] [Related]
36. [Antimetabolites and pregnancy. Normal child born to a mother under treatment 8 years for chronic myeloid leukemia]. Salmon M; Orsini A; Giraud F; Perrimond H; Gonggryp N Bull Acad Natl Med; 1972 Feb; 156(4):123-32. PubMed ID: 4629812 [No Abstract] [Full Text] [Related]
37. Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemia. Rushing D; Goldman A; Gibbs G; Howe R; Kennedy BJ Am J Clin Oncol; 1982 Jun; 5(3):307-13. PubMed ID: 6952759 [TBL] [Abstract][Full Text] [Related]
38. Immunotherapy for chronic myelogenous leukemia: survival not affected by treatment in the stable phase. Baker MA; Taub RN; Carter WH; Davidson M; Sutton DM; Kutas G; Berger S; Watt HJ Cancer Res; 1984 Jan; 44(1):383-5. PubMed ID: 6360347 [TBL] [Abstract][Full Text] [Related]
39. [Splenectomy in myeloid chronic leukemia in the pre-blastic phase. Presentation of 3 clinical cases and analysis of literature]. del Vecchio T; Carlesimo F; Cortese M Ann Ital Chir; 1976; 48(1):111-7. PubMed ID: 1070927 [No Abstract] [Full Text] [Related]
40. Hydroxyurea its value in 50 cases of advanced cancers. Patel D Indian J Cancer; 1973 Dec; 10(4):423-7. PubMed ID: 4525643 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]